#160909

REME009-2 Uterine corpus cancer organoid

Cat. #160909

REME009-2 Uterine corpus cancer organoid

Cat. #: 160909

Sub-type: Organoids

Unit size: 40-100 uL of cell pellet/vial, 1ml

Organism: Human

Tissue: Uterus

£2,500.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Medical-Industrial Translational Research Center

Institute: Fukushima Medical University

Primary Citation: Tamura et al. 2018. Oncology reports 40: 635-646. PMID: 29917168

Tool Details
Handling
Application Details
References
Documentation

Tool Details

*FOR RESEARCH USE ONLY

  • Tool name: REME009-2 Uterine corpus cancer organoid
  • Alternate name: REME009-2, REME9-2, REME9, REME009
  • Cancer: Gynaecologic cancer
  • Cancers detailed: Endometrioid carcinoma with squamous differentiation;Uterine corpus
  • Research fields: Cancer
  • Tool sub type: Organoids
  • Organism: Human
  • Tissue: Uterus
  • Gender: Female
  • Growth properties: Suspension
  • Application: 3D cell culture, High-throughput screening, Xenograft model
  • Description: A series of novel patient-derived organoids (PDOs) have been constructed from different tumor tissue types under the Fukushima Translational Research Project, designated as F-PDO. F-PDOs form large cell clusters with a morphology similar to the original tumor and can be cultured for more than six months. Our comparative histological and comprehensive gene expression analyses have shown that the characteristics of F-PDOs were similar to their source tumors, even after long-term growth in culture conditions
  • Biosafety level: 1

Handling

  • Format: Frozen
  • Passage number: 5
  • Growth medium: Cancer Cell Expansion Media (Fujifilm Wako Pure Chemical, Ltd.).
  • Temperature: 37° C
  • Atmosphere: 5% CO2
  • Volume: 1 ml
  • Storage medium: CELLBANKER 2
  • Storage conditions: Liquid Nitrogen
  • Shipping conditions: Dry ice
  • Characterisation tests: Pathogen and stelility test; Comprehensive gene expression analysis; Cancer panel sequencing; Whole exome sequencing; Anticancer drug susceptibility testing
  • Mycoplasma free: Yes
  • Biosafety level: 1

Application Details

  • Application: 3D cell culture, High-throughput screening, Xenograft model

References

  • Tamura et al. 2018. Oncology reports 40: 635-646. PMID: 29917168

Documentation